DUOX1 and lung carcinoma: In summary, our findings indicate that DUOX1 silencing, a common finding in epithelial cancers, including lung cancer,12, 20, 21 may be a strong determinant of increased invasive or metastatic potential, as well as resistance to conventional anticancer therapies.